Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III–IV squamous cancers of the head and neck
- 31 August 1987
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 13 (8), 1155-1160
- https://doi.org/10.1016/0360-3016(87)90188-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Failure of misonidazole to improve outcome in advanced h&n squamous cancersInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Primary radiotherapy of larynx and pharynx carcinoma—An analysis of some factors influencing local control and survivalInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Hypoxic cell radiosensitizers: Expectations and progress in drug developmentInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508International Journal of Radiation Oncology*Biology*Physics, 1984
- Clinical trials with hypoxic cell sensitizers: Time to retrench or time to push forward?International Journal of Radiation Oncology*Biology*Physics, 1984
- The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: An rtog pilot study (#78-02)International Journal of Radiation Oncology*Biology*Physics, 1981
- Radiation therapy oncology group clinical trials with misonidazoleCancer, 1981
- Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958